Noah ES Surpasses 5,000 Subscribers Worldwide
The cloud-based service has more than doubled its user base in the last year, attracting hearing care businesses with features like remote access and simplified data management.
Read MoreThe cloud-based service has more than doubled its user base in the last year, attracting hearing care businesses with features like remote access and simplified data management.
Read MoreThe partnership aims to explore the integration of novel drug-delivery methods with future cochlear implant technology.
Read MoreThe new premium family includes three zinc-air battery styles and features Oticon’s BrainHearing technology platform.
Read MoreOticon will present its newest hearing technology at the upcoming audiology conference.
Read MoreThe 8th International Conference on Hyperacusis and Misophonia will be held as part of the EUHA Congress in October 2026, with a call for abstracts now open.
Read MoreThe bimodal neuromodulation device is now available through select hearing care clinics across five provinces.
Read MoreIHS will celebrate the milestone with year-long events under the theme “Uniting Generations, Advancing Hearing Care.”
Read MoreThe audiologist and researcher was hired to help accelerate the company’s clinical research in aural rehabilitation.
Read MoreThe contribution to the American Academy of Audiology Foundation will fund scholarships and humanitarian missions for the 2026–27 academic year.
Read MoreThe audiology and public health researcher will fill the newly created role of vice president of audiology innovation and research.
Read MoreThe program is designed to help audiologists offer hearing aid jewelry to patients without carrying inventory risk.
Read MoreThe former Cochlear executive brings extensive digital health experience to the hearing care practice management software company.
Read MoreThe agreement aims to increase access to Natus Sensory’s diagnostic audiology solutions for hearing healthcare practices by leveraging Oaktree’s established network.
Read MoreThe company highlights progress in its SENS-501 and GJB2-GT clinical programs, recent financing, and a leadership transition.
Read MoreThe company will focus on its core hearing instrument and cochlear implant businesses going forward.
Read More